GRIFOLS SA ADR

NASDAQ: GRFS (Grifols, S.A.)

Last update: 4 days ago, 2:48AM

8.73

0.04 (0.46%)

Previous Close 8.69
Volume 441,007
Price / Earnings (Forward) 7.26
Price / Sales 0.680
Price / Book 0.900
52 Weeks Range
6.96 (-20%) — 9.77 (11%)
TTM Dividend Yield 1.08%
Profit Margin 2.65%
Operating Margin (TTM) 16.42%
Diluted EPS (TTM) 0.270
Quarterly Revenue Growth (YOY) 9.80%
Quarterly Earnings Growth (YOY) 178.80%
Total Debt/Equity (MRQ) 121.14%
Current Ratio (MRQ) 2.60
Operating Cash Flow (TTM) 1.20 B
Levered Free Cash Flow (TTM) 2.26 B
Return on Assets (TTM) 3.99%
Return on Equity (TTM) 3.45%

AIStockmoo Score

1.1
Cheaper than its usual valuation. Counted for less, as its earnings have been uneven. info
Earns below its cost of capital. Returns on capital falling. info
High debt. Weak profitability. Ample short-term liquidity. Positive cash flow. info
From our AI Insight report's view of expected return against risk. info NA
Relative Valuation info NA
Implied Growth info NA
Holdings' Value info NA
Risk Premium info NA
Market Valuation info NA
Downtrend over the past year. Somewhat below its 52-week high. info
In an uptrend: the price is above its moving averages, and they are rising. It is close to them. Volume is heavier on up days. info
From our AI technical analysis of the chart. info NA
Candle Patterns info NA
No recent price targets, so based on how targets have been revised. info
Holdings' Sentiment info NA
News Mood info NA
Institutions net +2.76% of shares in their latest 13F filings: 86 holders increased, 72 decreased (quarter to 30 Sep 2026). info
Short interest +75.0% from 31 Aug to 30 Oct 2026, 8.1 days to cover (FINRA). info
Insider Activity info NA
Market environment cautious. info
Sector outperforming the market.
The pillars agree, so the score is strengthened.
Earnings per share have gone up and down. Earnings have been uneven. info
Above its medium-term trend line. info
Price is high against its 52-week average. Down over 5 years. info
Short-term momentum rising. info
Price is near resistance. Levels trending up. info
Final Score 1.07
Show all

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - General (US) Mixed Bullish
Drug Manufacturers - General (Global) Mixed Bullish
Stock Grifols, S.A. Mixed Bearish

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B Score
GRFS - 1.08% - 0.900 1.1
BIIB - - - 1.98 0.8
SNY 112 B 5.21% 23.14 1.37 0.3
AMGN 236 B 2.28% 25.25 16.73 1.0
GILD 206 B 1.95% - 16.08 0.6
MIRA 15 M - 36.83 3.72 -1.0

Select this tab to load the latest available analysis.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Sector Healthcare
Industry Drug Manufacturers - General
Investment Style Mid Value
% Held by Institutions 58.60%

No data within this time range.

No data within this time range.

Institutions

Institutional ownership: 56.23%

Positions Holders Shares
Increased 86 10,179,899
Decreased 72 6,444,970
New 18 3,772,224
Sold out 18 312,746

SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.

Short Interest

Settlement Shares Days to cover
30 Oct 2026 5,978,971 8.1
15 Oct 2026 6,990,415 15.9
30 Sep 2026 7,001,241 8.7
15 Sep 2026 3,414,455 8.8
31 Aug 2026 3,417,230 8.4
14 Aug 2026 3,516,392 9.8

FINRA short interest via Nasdaq, reported twice a month.

1 Positive 1 Negative 0 Neutral
Date Type Details
03 Nov 2026 Yahoo Finance Grifols (BME:GRF) Stock Price Trails Q3 Results As Debt Questions Linger
Grifols just printed its Q3 2026 report and the story is not the share price. The stock closed at €11.23 on 3 November, well below a stated cash flow value estimate of €36.08, even as the plasma giant delivered adjusted EBITDA of €538m with a 26.4% margin and net leverage of about 3.98x. This is a…
03 Nov 2026 Yahoo Finance Grifols Beats Q3 Revenue Forecasts as Immunoglobulin Demand Supports Profit Growth
Grifols (NASDAQ:GRFS) reported stronger-than-expected third-quarter revenue, supported by continued growth in its Biopharma division and rising demand for immunoglobulin products. The Spanish pharmaceutical company also delivered higher profitability, improved cash generation and a reduction in…
03 Nov 2026 Yahoo Finance Grifols SA (GRFS) Q3 2026 Earnings Call Highlights: Biopharma Growth Accelerates as Margin ...
Grifols SA (GRFS) posted 8.4% constant-currency revenue growth and a 26.4% adjusted EBITDA margin in Q3 2026, while navigating China albumin headwinds and Diagnostics declines.
02 Nov 2026 Yahoo Finance Grifols (GRFS) Q3 2026 Earnings Call Transcript
Biopharma revenue grew 10.3% as net leverage fell below 4.0x.
02 Nov 2026 Yahoo Finance Grifols Q3 Earnings Call Highlights
Grifols (NASDAQ:GRFS) reported third-quarter 2026 results marked by revenue growth, expanding profitability, stronger free cash flow and lower leverage, while management reiterated its full-year financial targets despite continued weakness in China’s albumin market. Chief Executive Officer Nacho Ab…
02 Nov 2026 Yahoo Finance Grifols Q3 revenue exceeds estimates as immunoglobulin sales drive growth
Investing.com -- Grifols reported third-quarter revenue above expectations on Monday, driven by growth in its Biopharma business, and confirmed its full-year guidance. The company’s U.S.-listed shares closed 5% higher in the Monday session but slipped 1.4% in premarket trading Tuesday.
02 Nov 2026 Yahoo Finance European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
European equities traded in the US as American depositary receipts began the week tracking higher la…
30 Oct 2026 Yahoo Finance European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading
European equities traded in the US as American depositary receipts were down 0.59% to 1,896.05 on th…
27 Oct 2026 Yahoo Finance Grifols (BME:GRF) Stock Still Looks Cheap Based On Current Earnings
Grifols has seen sharp swings over recent years, and that kind of ride naturally raises a blunt question for you as an investor: Does the current share price line up with what the business is actually earning today? The stock has fallen 44.9% over the past 5 years, which puts the spotlight firmly…
26 Oct 2026 Yahoo Finance European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European equities traded in the US as American depositary receipts started the week higher late Mond…
23 Oct 2026 Yahoo Finance Plasma Demand Supports Grifols, S.A.’s (GRFS) Path Back to Financial Strength
White Falcon’s Q3 2026 letter reports 2.7% quarterly and 4.6% year-to-date net returns. The letter can be downloaded here. Management attributes the underperformance mainly to a sharp September pullback, rising interest rates, and zero energy exposure. The portfolio remains concentrated in…
14 Oct 2026 Yahoo Finance European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were marginally lower late Wednes…
11 Oct 2026 Yahoo Finance Can Ambu (CPSE:AMBU B) Look Undervalued As Board Changes Put Governance In Focus?
Boardroom shift puts governance in focus Ambu (CPSE:AMBU B) has drawn attention after appointing Jose Ignacio "Nacho" Abia as an observer to its Board of Directors, bringing experience from Grifols and more than two decades at Olympus. Recent trading has turned more upbeat for Ambu, with a 1-day…
07 Oct 2026 Yahoo Finance Are Options Traders Betting on a Big Move in Grifols Stock?
Investors need to pay close attention to GRFS stock based on the movements in the options market lately.
26 Sep 2026 Yahoo Finance Grifols (BME:GRF) Stock May Be Below Fair Value On Earnings
Grifols has seen a long share price slide in recent years, which naturally puts the focus on one question for investors who still follow the stock. Is the current price tag properly supported by the earnings the business is generating today. Over the past 5 years the share price has fallen 54%…
25 Sep 2026 Yahoo Finance European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
European equities traded in the US as American depositary receipts were tracking modestly higher lat…
Show more
TTM Dividend Yield 1.08%
5Y Average Dividend Yield 1.18%
Expected Next Dividend Payment Jul 2027
Ex Date Announcement Date Payment Date Details
03 Dec 2026 03 Nov 2026 11 Jan 2027 0.168574 Cash
02 Jul 2026 19 Jun 2026 09 Jul 2026 0.094458 Cash
12 Aug 2025 30 Jul 2025 20 Aug 2025 0.173385 Cash
03 Jun 2021 21 May 2021 14 Jun 2021 0.456586 Cash
30 Oct 2020 16 Oct 2020 09 Nov 2020 0.201439 Cash
02 Dec 2019 31 Oct 2019 11 Dec 2019 0.221872 Cash
07 Jun 2019 29 May 2019 18 Jun 2019 0.175638 Cash
30 Nov 2018 07 Nov 2018 11 Dec 2018 0.22789 Cash
01 Jun 2018 25 May 2018 12 Jun 2018 0.250975 Cash
01 Dec 2017 - 12 Dec 2017 0.212979 Cash
30 May 2017 - 08 Jun 2017 0.163528 Cash
05 Dec 2016 - 14 Dec 2016 0.193644 Cash
02 Jun 2016 - 15 Jun 2016 0.162059 Cash
10 Dec 2015 - 17 Dec 2015 0.384765 Cash
08 Jun 2015 - 15 Jun 2015 0.341846 Cash
04 Dec 2014 - 12 Dec 2014 0.312792 Cash
05 Jun 2013 24 May 2013 13 Jun 2013 0.258668 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2026 0.094 1 1.08
2025 0.173 1 1.85
2021 0.457 1 4.07
2020 0.201 1 1.09
2019 0.398 2 1.71
2018 0.479 2 2.61
2017 0.377 2 1.64
2016 0.356 2 2.21
2015 0.727 2 4.49
2014 0.313 1 1.84
2013 0.259 1 1.43
Show more

Technical Setup Medium

Trend order
Slope
Entry
Volume
In an uptrend: the price is above its moving averages, and they are rising. It is close to them. Volume is heavier on up days.
Nearest support: 8.36 – 8.53 · moderate level
Nearest resistance: 8.66 – 9.00 · strong level

AI Technical Analysis

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Risk / Reward
TP1:
TP2:

Loss to SL against profit to each target, from EP. A ratio of 2 or more is usually sought.

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria